- Over the 20 weeks following March 11, 2020, the volume of screening mammograms fell 58%, while diagnostic mammograms fell 38%.1
- A study in Washington State found the number of screening mammograms done between April and December 2020 dropped by 49% compared to the same period the year before.3
- It is estimated that delayed and missed screenings will likely increase breast cancer deaths by 7.9% to 9.6%.2
DECREASE IN SCREENINGS
- 49.2% in White patients
- 53.9% in Black patients
- 54.5% in Native Hawaiian or Pacific Islander patients
- 60.9% in American Indian/Alaska Native patients
- 64.2% in Latinx patients
- A substantial deficit of missed breast cancer screenings may worsen preexisting disparities.
- The differences by race/ethnicity reflect the effect of worry, competing priorities, limited access, and disproportionate burden and socioeconomic impact of COVID-19 in underserved communities.
- Healthcare systems should leverage COVID-19–related community outreach and engagement to develop concerted efforts that ensure preexisting disparities do not worsen among communities with higher risk.3
Read the full study in JAMA at bit.ly/JAMA_COVID19.